Axsome Therapeutics is likely on the cusp of its first drug approval, sending shares of its stock up more than 40% pre-market on Tuesday.
Analyses are shared at the American Association for Cancer Research Annual Meeting 2022 in New Orleans, Louisiana.
The FDA has approved Amneal Pharmaceuticals’ Alymsys (bevacizumab-maly) as a biosimilar of Roche’s blockbuster cancer drug Avastin.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.
